Article
Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli.
Antimicrobial agents and chemotherapy - 1 Dec 2015
Kotsakis S D, Miriagou V, Vetouli E E, Bozavoutoglou E, Lebessi E, Tzelepi E, Tzouvelekis L S
Abstract excerpt
The cephalosporinase CMY-107, a Tyr199Cys mutant form of CMY-2 encoded by an IncI self-transferable plasmid carried by an Escherichia coli clinical strain, was characterized. The enzyme hydrolyzed oximino-cephalosporins and aztreonam more efficiently than CMY-2 did.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
